Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu | (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats:
- Alabama Drug Discovery Alliance
- Biochemistry and Molecular Genetics
- Biomatrix Engineering and Regenerative Medicine
- Cell biology
- Center for Biophysical Sciences and Engineering
- CCTS
- Center for Metabolic Bone Disease
- Microbiology
- Neurobiology
- Comprehensive Neuroscience Center
- Pathology, research shared with MS2
- Pharmacology and Toxicology
- Physiology and Biophysics
- UAB Research Foundation/IIE
- Research Administration
These awards from the National Institute of Environmental Health Sciences recognize exceptional early-career scientists.
This protective effect on cardiotoxicity could benefit cancer chemotherapy recipients and heart failure patients.
A key role for microRNA-155 in brain inflammation and neurodegeneration makes it both a potential therapeutic target and a biomarker for this progressive disorder.
UAB researchers probe basic molecular mechanisms that lead to the lung scarring of pulmonary fibrosis, a lethal disorder.
Measure of Mpl gene expression reveals a heterogonous population of leukemia stem cells: one group leukemic and the other group non-leukemic.
The properties of cubic or spherical shape and solid or elastic stiffness affect the fates of polymer microcapsules meant to carry chemotherapy to a tumor.
One major goal is the discovery of new genotype/phenotype correlations — how a particular mutation indicates that some symptoms in patients are unlikely to develop with age.
The Sickle Cell Foundation has completed a $1 million gift to the UAB Adult Sickle Cell Clinic.
UAB researchers find that epigenetic changes associated with chronic obesity alter expression of memory-related genes in the brain.
Recognition of a new pathway may change the treatment of allergic diseases.